Overview

Propofol TCI Administered by Gastroenterologists During Endoscopy: a Randomized Double Blind Controlled Study

Status:
Completed
Trial end date:
2013-03-01
Target enrollment:
Participant gender:
Summary
Many studies address safety and effectiveness of non-anesthesiologist propofol sedation (NAPS) for GI endoscopy. Target Controlled Infusion (TCI) is a sophisticated tool for providing optimal sedation regimen and avoiding under or oversedation. This randomized double blind controlled study compares standard moderate sedation level of sedation (group S) during upper endoscopy (EGD) and colonoscopy (CS) versus propofol NAPS (group P).
Phase:
Phase 4
Details
Lead Sponsor:
Ospedale San Raffaele
Treatments:
Midazolam
Propofol